Mylan 28 June, 2017

Mylan is a global pharmaceutical company committed to setting new standards in healthcare and providing the world’s 7 billion people with access to high quality medicine.

They market their products in more than 165 countries and territories and have a portfolio of approximately 7,500 products, including antiretroviral therapies on which approximately 50% of people being treated for HIV/AIDS in the developing world depend.

In the UK, they have a large portfolio of over 500 products, covering critical therapeutic areas such as Allergy, Psychiatry and Respiratory which help patients and physicians manage and treat conditions relating to severe allergic reactions, psychiatric disorders and respiratory diseases. In addition, more than 55 million packs* (over 100 packs* per minute) of Mylan medicines are purchased in the UK each year for use in hospitals and pharmacies.

Mylan chose Discovery Park, Sandwich as a base for its Respiratory Centre of Excellence because the laboratories, manufacturing, warehousing and office facilities allow them to develop their respiratory medicines needed by patients around the world.  Having expanded their workforce significantly over the last five years, Mylan now occupies the largest square metre footprint of all tenants at the site.

Walter Cook, Mylan Global Respiratory Group Lead, said: “Mylan have been tenants at Discovery Park since its inception and the facilities our staff work in here are mission critical to the development of high quality respiratory therapies for patients worldwide.”

To find out more about Mylan’s UK operation, visit www.mylan.co.uk

* 2016 total sales volume (including all Mylan entities in the UK)

Twitter iconTweets